• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

PXXXIVXX details
Primary information
ID antitb_1884,
Name20483615
N-Terminal modificationTrichoderins A
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis
Cell LineMIC = 0.1 μg/mL
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1885,
Name20483615
N-Terminal modificationTrichoderins A
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium bovis
In Vitro/ In vivoMycobacterium bovis BCG
Cell LineMIC = 0.02 μg/ml
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1886,
Name20483615
N-Terminal modificationTrichoderins A
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37RV
Cell LineMIC = 0.12 μg/ml
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1887,
Name20483615
N-Terminal modificationTrichoderins A1
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis M341
Cell LineMIC = 1.56 μg/mL
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1888,
Name20483615
N-Terminal modificationTrichoderins A
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium bovis
In Vitro/ In vivoMycobacterium bovis BCG
Cell LineMIC = 0.16 μg/ml
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1889,
Name20483615
N-Terminal modificationTrichoderins A1
C-Terminal ModificationPXXXIVXX
Chemical ModificationAddition of MDA (2-methyl decanoic acid)
Linear/CyclicAddition of AMAE (2-[(20-aminopropyl) methylamino] ethanol)
LengthAddition of AHMOD at residue 2 (2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid) and AIB (a-aminoisobutyric acid) at 3,4,7, and 8
ChiralityCyclic
Nature8
SourceD
SpeciesNatural
StrainIsolated from Trichoderma species 05FI48
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37RV
Cell LineMIC = 2.0 μg/ml
Inhibition ConcentrationIn vitro
Sequence2010
CytotoxicityNA
In vivo ModelTratment with this concentration inhibit 100% bacterial growth
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesLipid bilayer
PMIDNA
Year of PublicationNA
Tertiary Structure
(Technique)
Not Predicted),